Skip to main content
Erschienen in: Supportive Care in Cancer 10/2017

24.04.2017 | Original Article

Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival

verfasst von: Amro Mohamed Sedky El-Ghammaz, Rima Ben Matoug, Maha Elzimaity, Nevine Mostafa

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients subjected to allogeneic hematopoietic stem cell transplantation (HSCT) are at increased nutritional risk which in turn may alter their outcome. For providing good nutritional care for patients, it is important to analyze risk factors influencing nutritional status during and after HSCT.

Methods

Fifty patients undergoing allogeneic HSCT were subjected to nutritional status assessment by using the patient-generated subjective global assessment (PG-SGA) at initial admission, day 30 and day 180.

Results

Two patients (4%) had malnutrition at admission, 36 (72%) at day 30, and 24 (48%) at day 180. At day 30, comorbidity index higher than 0 and fever lasting for more than 1 week had a significant impact on nutritional status (P = .004 and P = .006, respectively). Regarding day 180, comorbidity index higher than 0 and presence of ≥grade II acute gastrointestinal graft versus host disease (GI GVHD) significantly influenced nutritional status (P = .017 and P = .026, respectively). Well-nourished patients at admission and day 180 had a significantly higher overall survival (OS) in comparison to malnourished patients (P < .001 and P = .012, respectively). Nutritional status at admission and day 180 had a significant influence on OS in multivariate analysis (P = .039 and P = .032, respectively).

Conclusions

Allogeneic HSCT patients having high comorbidity index, developing prolonged fever, and experiencing ≥grade II acute GI GVHD suffer from worsening in their nutritional status during hospitalization and after discharge. Also, nutritional status at admission and day 180 significantly influences their survival.
Literatur
1.
Zurück zum Zitat Ljungman P, Bregni M, Brune M et al (2010) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 45:219–234CrossRefPubMed Ljungman P, Bregni M, Brune M et al (2010) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 45:219–234CrossRefPubMed
2.
Zurück zum Zitat Ferreira EE, Guerra DC, Baluz K, de Resende FW, da Silva Bouzas LF (2014) Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study. Rev Bras Hematol Hemoter 36:414–419CrossRefPubMedPubMedCentral Ferreira EE, Guerra DC, Baluz K, de Resende FW, da Silva Bouzas LF (2014) Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study. Rev Bras Hematol Hemoter 36:414–419CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Rzepecki P, Barzal J, Oborska S (2010) Blood and marrow transplantation and nutritional support. Support Care Cancer 18(Suppl. 2):S57–S65CrossRefPubMed Rzepecki P, Barzal J, Oborska S (2010) Blood and marrow transplantation and nutritional support. Support Care Cancer 18(Suppl. 2):S57–S65CrossRefPubMed
4.
Zurück zum Zitat Zatarain L, Savani BN (2012) The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation. Cell Immunol 276:6–9CrossRefPubMed Zatarain L, Savani BN (2012) The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation. Cell Immunol 276:6–9CrossRefPubMed
5.
Zurück zum Zitat Akbulut G (2013) Medical nutritional in hematopoietic stem cell transplantation (HSCT). Int J Hematol Oncol 1:55–65CrossRef Akbulut G (2013) Medical nutritional in hematopoietic stem cell transplantation (HSCT). Int J Hematol Oncol 1:55–65CrossRef
6.
Zurück zum Zitat Arnaud-Battandier F, Malvy D, Jeandel C et al (2004) Use of oral supplements in malnourished elderly patients living in the community: a pharmaco-economic study. Clin Nutr 23:1096–1103CrossRefPubMed Arnaud-Battandier F, Malvy D, Jeandel C et al (2004) Use of oral supplements in malnourished elderly patients living in the community: a pharmaco-economic study. Clin Nutr 23:1096–1103CrossRefPubMed
7.
Zurück zum Zitat Fuji S, Mori T, Khattry N et al (2015) Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality. Bone Marrow Transplant 50:100–105CrossRefPubMed Fuji S, Mori T, Khattry N et al (2015) Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality. Bone Marrow Transplant 50:100–105CrossRefPubMed
8.
Zurück zum Zitat Horsley P, Bauer J, Gallagher B (2005) Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant 35:1113–1116CrossRefPubMed Horsley P, Bauer J, Gallagher B (2005) Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant 35:1113–1116CrossRefPubMed
9.
Zurück zum Zitat Raja R, Lim AV, Lim YP, Lim G, Chan SP, Vu CK (2004) Malnutrition screening in hospitalised patients and its implication on reimbursement. Intern Med J 34:176–181CrossRefPubMed Raja R, Lim AV, Lim YP, Lim G, Chan SP, Vu CK (2004) Malnutrition screening in hospitalised patients and its implication on reimbursement. Intern Med J 34:176–181CrossRefPubMed
10.
Zurück zum Zitat Fine JT, Colditz GA, Coakley EH et al (1999) A prospective study of weight change and health-related quality of life in women. JAMA 282:2136–2142CrossRefPubMed Fine JT, Colditz GA, Coakley EH et al (1999) A prospective study of weight change and health-related quality of life in women. JAMA 282:2136–2142CrossRefPubMed
11.
Zurück zum Zitat Jones L, Watling RM, Wilkins S, Pizer B (2010) Nutritional support in children and young people with cancer undergoing chemotherapy. Cochrane Database Syst Rev 7:CD003298 Jones L, Watling RM, Wilkins S, Pizer B (2010) Nutritional support in children and young people with cancer undergoing chemotherapy. Cochrane Database Syst Rev 7:CD003298
12.
Zurück zum Zitat So EJ, Lee JS, Kim JY (2012) Nutritional intake and nutritional status by the type of hematopoietic stem cell transplantation. Clin Nutr Res 1:3–12CrossRefPubMedPubMedCentral So EJ, Lee JS, Kim JY (2012) Nutritional intake and nutritional status by the type of hematopoietic stem cell transplantation. Clin Nutr Res 1:3–12CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wang B, Yan X, Cai J, Wang Y, Liu P (2013) Nutritional assessment with different tools in leukemia patients after hematopoietic stem cell transplantation. Chin J Cancer Res 25:762–769PubMedPubMedCentral Wang B, Yan X, Cai J, Wang Y, Liu P (2013) Nutritional assessment with different tools in leukemia patients after hematopoietic stem cell transplantation. Chin J Cancer Res 25:762–769PubMedPubMedCentral
14.
Zurück zum Zitat White M, Murphy AJ, Hastings Y et al (2005) Nutritional status and energy expenditure in children pre-bone-marrow transplant. Bone Marrow Transplant 35:775–779CrossRefPubMed White M, Murphy AJ, Hastings Y et al (2005) Nutritional status and energy expenditure in children pre-bone-marrow transplant. Bone Marrow Transplant 35:775–779CrossRefPubMed
15.
Zurück zum Zitat Jeejeebhoy KN, Detsky AS, Baker JP (1990) Assessment of nutritional status. J Parenter Enter Nutr 14:S193–S196CrossRef Jeejeebhoy KN, Detsky AS, Baker JP (1990) Assessment of nutritional status. J Parenter Enter Nutr 14:S193–S196CrossRef
16.
Zurück zum Zitat Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? J Parenter Enter Nutr 11:8–13CrossRef Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? J Parenter Enter Nutr 11:8–13CrossRef
17.
Zurück zum Zitat Stratton RJ, Hackston A, Longmore D et al (2004) Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr 92:799–808CrossRefPubMed Stratton RJ, Hackston A, Longmore D et al (2004) Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr 92:799–808CrossRefPubMed
18.
Zurück zum Zitat Vellas B, Guigoz Y, Garry PJ et al (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122CrossRefPubMed Vellas B, Guigoz Y, Garry PJ et al (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122CrossRefPubMed
19.
Zurück zum Zitat Kondrup J, Allison SP, Elia M, Vellas B, Plauth M (2003) ESPEN guidelines for nutrition screening 2002. Clin Nutr 22:415–421CrossRefPubMed Kondrup J, Allison SP, Elia M, Vellas B, Plauth M (2003) ESPEN guidelines for nutrition screening 2002. Clin Nutr 22:415–421CrossRefPubMed
20.
Zurück zum Zitat Urbain P, Birlinger J, Lambert C, Finke J, Bertz H, Biesalski HK (2013) Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48:446–451CrossRefPubMed Urbain P, Birlinger J, Lambert C, Finke J, Bertz H, Biesalski HK (2013) Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48:446–451CrossRefPubMed
21.
Zurück zum Zitat Mustian KM, Devine K, Ryan JL et al (2011) Treatment of nausea and vomiting during chemotherapy. US Oncol Hematol 7(2):91–97PubMedPubMedCentral Mustian KM, Devine K, Ryan JL et al (2011) Treatment of nausea and vomiting during chemotherapy. US Oncol Hematol 7(2):91–97PubMedPubMedCentral
22.
Zurück zum Zitat Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93CrossRefPubMed Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93CrossRefPubMed
23.
Zurück zum Zitat Ottery FD (1994) Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Sem Oncol 21:770–778 Ottery FD (1994) Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Sem Oncol 21:770–778
24.
Zurück zum Zitat Sorror ML, Maris MB, Storb R et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919CrossRefPubMedPubMedCentral Sorror ML, Maris MB, Storb R et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hannan WJ, Wrate RM, Cowen SJ, Freeman CP (1995) Body mass index as an estimate of body fat. Int J Eat Disord 18:91–97CrossRefPubMed Hannan WJ, Wrate RM, Cowen SJ, Freeman CP (1995) Body mass index as an estimate of body fat. Int J Eat Disord 18:91–97CrossRefPubMed
26.
Zurück zum Zitat World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO Offset publication No. 48, Geneva World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO Offset publication No. 48, Geneva
27.
Zurück zum Zitat Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW (2003) Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 41:187–191CrossRefPubMedPubMedCentral Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW (2003) Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 41:187–191CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032–2036CrossRefPubMed Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032–2036CrossRefPubMed
29.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821CrossRefPubMedPubMedCentral De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Rowlings PA, Przepiorka D, Klein JP et al (1997) IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97:855–864CrossRefPubMed Rowlings PA, Przepiorka D, Klein JP et al (1997) IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97:855–864CrossRefPubMed
31.
Zurück zum Zitat Rzepecki P, Barzal J, Sarosiek T, Szczylik C (2007) Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience. Bone Marrow Transplant 40:567–572CrossRefPubMed Rzepecki P, Barzal J, Sarosiek T, Szczylik C (2007) Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience. Bone Marrow Transplant 40:567–572CrossRefPubMed
32.
Zurück zum Zitat Schulte C, Reinhardt W, Beelen D, Mann K, Schaefer U (1998) Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant 22:1171–1178CrossRefPubMed Schulte C, Reinhardt W, Beelen D, Mann K, Schaefer U (1998) Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant 22:1171–1178CrossRefPubMed
33.
Zurück zum Zitat Fleming DR, Rayens MK, Garrison J (1997) Impact of obesity on allogeneic stem cell transplant patients: a matched case–controlled study. Am J Med 102:265–268CrossRefPubMed Fleming DR, Rayens MK, Garrison J (1997) Impact of obesity on allogeneic stem cell transplant patients: a matched case–controlled study. Am J Med 102:265–268CrossRefPubMed
34.
Zurück zum Zitat Le Blanc K, Ringden O, Remberger M (2003) A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88:1044–1052PubMed Le Blanc K, Ringden O, Remberger M (2003) A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88:1044–1052PubMed
35.
Zurück zum Zitat Nikolousis E, Nagra S, Paneesha S et al (2010) Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Ann Hematol 89:1141–1145CrossRefPubMed Nikolousis E, Nagra S, Paneesha S et al (2010) Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Ann Hematol 89:1141–1145CrossRefPubMed
36.
Zurück zum Zitat Wigmore SJ, Plester CE, Richardson RA, Fearon KCH (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75:106–109CrossRefPubMedPubMedCentral Wigmore SJ, Plester CE, Richardson RA, Fearon KCH (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75:106–109CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Santarpia L, Contaldo F, Pasanisi F (2011) Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2:27–35CrossRefPubMedPubMedCentral Santarpia L, Contaldo F, Pasanisi F (2011) Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2:27–35CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Fruchtenicht AVG, Poziomyck AK, Kabke GB et al (2015) Nutritional risk assessment in critically ill cancer patients: systematic review. Rev Bras Ter Intensiva 27:274–283PubMedPubMedCentral Fruchtenicht AVG, Poziomyck AK, Kabke GB et al (2015) Nutritional risk assessment in critically ill cancer patients: systematic review. Rev Bras Ter Intensiva 27:274–283PubMedPubMedCentral
39.
Zurück zum Zitat van Bokhorst-de van der Schueren MA, Guaitoli PR, Jansma EP, de Vet HC (2014) Nutrition screening tools: does one size fit all? A systematic review of screening tools for the hospital setting. Clin Nutr 33:39–58CrossRefPubMed van Bokhorst-de van der Schueren MA, Guaitoli PR, Jansma EP, de Vet HC (2014) Nutrition screening tools: does one size fit all? A systematic review of screening tools for the hospital setting. Clin Nutr 33:39–58CrossRefPubMed
40.
Zurück zum Zitat Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785CrossRefPubMed Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785CrossRefPubMed
41.
Zurück zum Zitat Barritta de Defranchi RLB, Bordalejo A, Cañueto I, Villar A, Navarro E (2015) Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant. Support Care Cancer 23:1341–1347CrossRefPubMed Barritta de Defranchi RLB, Bordalejo A, Cañueto I, Villar A, Navarro E (2015) Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant. Support Care Cancer 23:1341–1347CrossRefPubMed
42.
Zurück zum Zitat LaPier TK (1997) Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention J Cardiopulm Rehabil 17:76–84CrossRefPubMed LaPier TK (1997) Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention J Cardiopulm Rehabil 17:76–84CrossRefPubMed
43.
Zurück zum Zitat Biring MS, Fournier M, Ross DJ, Lewis MI (1998) Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol 84:1967–1975PubMed Biring MS, Fournier M, Ross DJ, Lewis MI (1998) Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol 84:1967–1975PubMed
44.
Zurück zum Zitat Murphy CL, Sheane BJ, Cunnane G (2011) Attitudes towards exercise in patients with chronic disease: the influence of comorbid factors on motivation and ability to exercise. Postgrad Med J 87:96–100CrossRefPubMed Murphy CL, Sheane BJ, Cunnane G (2011) Attitudes towards exercise in patients with chronic disease: the influence of comorbid factors on motivation and ability to exercise. Postgrad Med J 87:96–100CrossRefPubMed
45.
Zurück zum Zitat Hayes S, Davies PS, Parker T, Bashford J (2003) Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme. Bone Marrow Transplant 31:331–338CrossRefPubMed Hayes S, Davies PS, Parker T, Bashford J (2003) Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme. Bone Marrow Transplant 31:331–338CrossRefPubMed
46.
Zurück zum Zitat Pereira PCM (2003) Interaction between infection, nutrition and immunity in tropical medicine. J Venom Anim Toxins Incl Trop Dis 9:163–173CrossRef Pereira PCM (2003) Interaction between infection, nutrition and immunity in tropical medicine. J Venom Anim Toxins Incl Trop Dis 9:163–173CrossRef
47.
Zurück zum Zitat Urbain P, Birlinger J, Ihorst G, Biesalski H, Finke J, Bertz H (2013) Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol 92:111–119CrossRefPubMed Urbain P, Birlinger J, Ihorst G, Biesalski H, Finke J, Bertz H (2013) Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol 92:111–119CrossRefPubMed
Metadaten
Titel
Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival
verfasst von
Amro Mohamed Sedky El-Ghammaz
Rima Ben Matoug
Maha Elzimaity
Nevine Mostafa
Publikationsdatum
24.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3716-6

Weitere Artikel der Ausgabe 10/2017

Supportive Care in Cancer 10/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.